To: Alighieri who wrote (846552 ) 3/31/2015 1:46:16 PM From: i-node Respond to of 1574980 >> Wow...did you take moderation pills over the weekend...until then the system was in "total collapse". Make no mistake; I've not moderated a bit. The ACA was the worst piece of legislation, imo, ever enacted, and having done it illegally makes it even worse. In every respect: Quality of care, lack of affordability, effect on innovation, and the sheer number of deaths that will result from people who cannot afford to interact with the system. All of it is terrible and pretty much the worst thing I can envision a government doing to its people short of gassing them like Saddam. >> Did you watch 60mins this sunday? The piece on glioblastoma research at Duke? Amazing work. I did, and while concerns are being raised about the reporting of it, it looks pretty impressive to me. >> ..innovation has its own momentum. >> ..ACA won't change any of that... "The overwhelming majority of the world's health-care innovation occurs in the U.S . This includes ground-breaking drug treatments, surgical procedures, medical devices, patents, diagnostics and much more. Most of the funding for that innovation—about 71% of U.S. R&D investment—comes from private industry. A recent R&D Magazine survey of industry leaders in 63 countries ranked the U.S. No. 1 in the world for health-care innovation. But that environment is changing. According to R&D Magazine and the research firm Battelle, growth of R&D spending in the U.S. from 2012 to 2014 averaged just 2.1%, down from an average of 6% over the previous 15 years. In that same 15-year period, Malaysia, Thailand, Singapore, South Korea, India and the European Union saw faster R&D spending growth than the U.S. China's grew on average 22% per year. The recent slowdown in R&D spending in the U.S. is in part caused by weak economic growth since the 2008 financial crisis. But the economy's weakness itself has been exacerbated by the negative impact of new taxes and regulations under ObamaCare. According to Congressional Budget Office estimates, the new health-care law will levy more than $500 billion in new taxes over its first 10 years to help pay for insurance subsidies and Medicaid expansion. These new taxes include significant levies on key health-care industries, such as manufacturers of medical devices and drugs, and their investors. As a result, small and large U.S. health-care technology companies are moving R&D centers and jobs overseas. The CEO of one of the largest health-care companies in America recently told me that the device tax his company paid last year exceeded his company's entire R&D budget. Already a long list of companies—including Boston Scientific , Stryker and Cook Medical—have announced job cuts and plans to open new centers for R&D, manufacturing and clinical trials overseas ." wsj.com Reality sets in: We're driving away the goose that laid the golden egg: Medical Research. Now, one could argue, "Why should we care, as long as it gets done?" The answer is that research we perform benefits the United States the most. I would point out that this is yet another thing I (and many others) told you up front was going to happen. There was never any doubt about it. Again, it takes time to build facilities and operations in other countries so it is just getting started, but it is already plainly visible. The Dean of Harvard Medical said it as far back as 2009 -- the law is an innovation killer. >> Why would it make things better for them? Better for patients was what I was referring to. >> from their posh homes and surroundings. I know plenty of doctors who don't live in 5000 s/f homes or have a vacation home in Florida as you do. So what is this BS about "posh homes and surroundings". And I know one HELL of a lot of nurses and other medical personnel who certainly are not living in your "posh" surroundings. That is hilarious coming from you.